A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that stopped influenza and COVID-19 in animal trials.
source https://www.sciencedaily.com/releases/2025/08/250818102957.htm
No comments:
Post a Comment